JSC Scientific Center for Anti-infectious Drugs Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00334386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

JSC Chernaya Rechka Health Center, St. Petesburg, Russia

Active Ingredients

Drugs in Phase 4 Trials (1)

torsemide (demadex) (1 trial)

Drugs in Phase 3 Trials (1)

Efesovir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Tuberculosis (Phase 3)

Tuberculosis, Multidrug-Resistant (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2